These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 35460461

  • 1. Multicenter retro-prospective observational study on chronic hypoparathyroidism and rhPTH (1-84) treatment.
    Marcucci G, Beccuti G, Carosi G, Cetani F, Cianferotti L, Colao AM, Di Somma C, Duradoni M, Elefante A, Ghizzoni L, Giusti M, Lania AG, Lavezzi E, Madeo B, Mantovani G, Marcocci C, Masi L, Parri S, Pigliaru F, Santonati A, Spada A, Vera L, Brandi ML.
    J Endocrinol Invest; 2022 Sep; 45(9):1653-1662. PubMed ID: 35460461
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL, Kay Berg J, Fox J, Cyran JA, Lagast H.
    Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
    [Abstract] [Full Text] [Related]

  • 3. Extended Treatment With Recombinant Human Parathyroid Hormone (1-84) in Adult Patients With Chronic Hypoparathyroidism.
    Rubin MR, Cusano N, Yin S, Tokareva E, Ayodele O, Finkelman RD.
    Endocr Pract; 2024 Mar; 30(3):200-208. PubMed ID: 38086524
    [Abstract] [Full Text] [Related]

  • 4. Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study.
    Clarke BL, Vokes TJ, Bilezikian JP, Shoback DM, Lagast H, Mannstadt M.
    Endocrine; 2017 Jan; 55(1):273-282. PubMed ID: 27734257
    [Abstract] [Full Text] [Related]

  • 5. AN OPEN-LABEL EXTENSION STUDY OF PARATHYROID HORMONE RHPTH(1-84) IN ADULTS WITH HYPOPARATHYROIDISM.
    Lakatos P, Bajnok L, Lagast H, Valkusz Z.
    Endocr Pract; 2016 May; 22(5):523-32. PubMed ID: 26684150
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics.
    Gittoes N, Rejnmark L, Ing SW, Brandi ML, Björnsdottir S, Hahner S, Hofbauer LC, Houillier P, Khan AA, Levine MA, Mannstadt M, Shoback DM, Vokes TJ, Zhang P, Marelli C, Germak J, Clarke BL.
    BMC Endocr Disord; 2021 Nov 20; 21(1):232. PubMed ID: 34801015
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recombinant human parathyroid hormone (1-84) replacement therapy in a child with hypoparathyroidism.
    Laurer E, Grünberger J, Naidoo U, Lanzersdorfer R, Wimleitner M, Tischlinger K, Högler W.
    Bone; 2021 Mar 20; 144():115834. PubMed ID: 33359892
    [Abstract] [Full Text] [Related]

  • 11. Teriparatide (rhPTH 1-34) treatment in the pediatric age: long-term efficacy and safety data in a cohort with genetic hypoparathyroidism.
    Tuli G, Buganza R, Tessaris D, Einaudi S, Matarazzo P, de Sanctis L.
    Endocrine; 2020 Feb 20; 67(2):457-465. PubMed ID: 31705387
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment.
    Sikjaer T, Amstrup AK, Rolighed L, Kjaer SG, Mosekilde L, Rejnmark L.
    J Bone Miner Res; 2013 Oct 20; 28(10):2232-43. PubMed ID: 23649554
    [Abstract] [Full Text] [Related]

  • 15. Five-Year Estimated Glomerular Filtration Rate in Adults with Chronic Hypoparathyroidism Treated with rhPTH(1-84): A Retrospective Cohort Study.
    Ayodele O, Rejnmark L, Mu F, Lax A, Berman R, Swallow E, Gosmanova EO.
    Adv Ther; 2022 Nov 20; 39(11):5013-5024. PubMed ID: 36018496
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism.
    Watts NB, Bilezikian JP, Bone HG, Clarke BL, Denham D, Levine MA, Mannstadt M, Peacock M, Rothman JG, Vokes TJ, Warren ML, Yin S, Sherry N, Shoback DM.
    J Endocr Soc; 2023 Mar 06; 7(5):bvad043. PubMed ID: 37091306
    [Abstract] [Full Text] [Related]

  • 20. Continuous rhPTH (1-34) treatment in chronic hypoparathyroidism.
    Fuss CT, Burger-Stritt S, Horn S, Koschker AC, Frey K, Meyer A, Hahner S.
    Endocrinol Diabetes Metab Case Rep; 2020 May 29; 2020():. PubMed ID: 32478671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.